Table 1.

Baseline characteristics, laboratory findings, procedural characteristics of the studied populations.

	Group A n = 364		Group B n = 270		p-Value
Age
Range	36–88		35–82		0.568
Mean ± S.D.	58.9 ± 13.35		57.1 ± 12.60
Gender
Male	312	85.7%	220	81.5%	0.607
Female	52	14.3%	50	18.5%
Risk factors
Diabetes mellitus	130	35.7%	95	35.2%	0.521
Hypertension	156	42.9%	107	39.6%	0.411
Dyslipidemia	182	50.0%	122	45.2%	0.501
Smoking	208	57.1%	123	45.6%	0.364
Troponin
Range	0.003–8.68		0.01–10.0		0.078
Mean ± S.D.	1.07 ± 2.21		1.65 ± 2.62
CKmb
Range	1.27–261.9		1.32–270.0		0.105
Mean ± S.D.	115.94 ± 76.29		124.3 ± 58.9
Haemoglobin
Range	9.3–17.1		9.5–16.0		0.524
Mean ± S.D.	13.87 ± 1.85		13.9 ± 1.71
Lymphocytes
Range	12–36		8–25		0.012 *
Mean ± S.D.	18.6 ± 6.21		14.78 ± 5.85
D dimer
Range	130–500		152–1500		0.0031 *
Mean ± S.D.	302.0 ± 132.17		505.6 ± 201.3
Serum ferritin
Range	72.0–135.0		85.0–166.0		0.011 *
Mean ± S.D.	93.48 ± 39.8		118.5 ± 42.51
Serum creatinine
Range	0.59–4.03		0.60–3.52		0.211
Mean ± S.D.	1.12 ± 0.66		1.26 ± 0.71
FMC-to-N (min)
Range	15–85		60.0–280		0.001 *
Mean ± S.D.	52.6 ± 22.8		125.0 ± 53.6
	No.	%	No.	%
MVD SVD	43 321	11.8 88.2	63 207	23.3 76.7	0.389
Culprit vessel
LAD	216	59.3	128	47.4	0.089
RCA	108	29.7	97	35.9
LCX	40	11	45	16.7
Clopidogrel Ticagrelor	221 143	60.7 39.3	155 115	57.3 42.7	0.410

p value for comparing between the two studied groups. *: Statistically significant at p ≤ 0.05.